What does “intelligence” mean in the context of biopharma analysis? Given the complex setting, much of the answer comes down to the task a user needs to complete, along with the question of who exactly… Read more >
Newborn screening for inherited disorders has been heralded as one of the 10 greatest public health achievements of the first decade of the 21st century.1 The ability to pre-symptomatically identify newborn babies at risk of… Read more >
We’ve updated our UPLC systems to enable you to find faster, simpler, and better ways to do your work. Take a closer look at our new and improved ACQUITY UPLC PLUS Series.
From oligonucleotides and peptides to messenger RNA and CRISPR, ’tides are enjoying their time in the sun A year ago we wrote how oligonucleotide therapeutic development, which had seen a huge wave of investment in… Read more >
In this webinar, we discussed the transfer of chromatographic methods that occurs at many stages in the development and production of a product. Here are a few questions that we received but did not have time to answer during the information-rich hour.
What are the differences between micro-scale and conventional LC? Microflow (a.k.a. microscale) LC has been widely applied to proteomic research for years. Recently, as microflow LC-MS systems continue to evolve, more and more laboratories in… Read more >
The European Bioanalysis Forum (EBF) is a non-profit organization comprised of bioanalytical scientists working within the pharmaceutical and CRO industries. EBF’s mission is to gather like-minded scientists to tackle the issues and challenges facing the… Read more >
